Digital Therapeutics Field Is Fast On The Rise, Ehave Is Advancing Research In Psychedelics And ADHD Therapy
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.
Ehave, Inc. (OTCMKTS:EHVVF) is a provider of digital therapeutics, delivering evidence-based therapeutic interventions to patients.
